Demonstration of safety of probiotics—A review
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Probiotics are commonly defined as viable microorganisms (bacteria or yeasts) that exhibit a beneficial effect on the health of the host when they are ingested. They are used in foods, especially in fermented dairy products, but also in pharmaceutical preparations. The development of new probiotic strains aims at more active beneficial organisms. In the case of novel microorganisms and modified organisms the question of their safety and the risk to benefit ratio have to be assessed. Lactic acid bacteria (LAB) in foods have a long history of safe use. Members of the genera Lactococcus and Lactobacillus are most commonly given generally-recognised-as-safe (GRAS) status whilst members of the genera Streptococcus and Enterococcus and some other genera of LAB contain some opportunistic pathogens. Lactic acid bacteria are intrinsically resistant to many antibiotics. In many cases resistances are not, however, transmissible, and the species are also sensitive to many clinically used antibiotics even in the case of a lactic acid bacteria- associated opportunistic infection. Therefore no particular safety concern is associated with intrinsic type of resistance. Plasmid-associated antibiotic resistance, which occasionally occurs, is another matter because of the possibility of the resistance spreading to other, more harmful species and genera. The transmissible enterococcal resistance against glycopeptide antibiotics (vancomycin and teicoplanin) is particularly noteworthy, as vancomycin is one of the last effective antibiotics left in the treatment of certain multidrug-resistant pathogens. New species and more specific strains of probiotic bacteria are constantly identified. Prior to incorporating new strains into products their efficacy should be carefully assessed, and a case by case evaluation as to whether they share the safety status of traditional food-grade organisms should be made. The current documentation of adverse effects in the literature is reviewed. Future recommendations for the safety of already existing and new probiotics will be given.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adhesion allows preservation in the gut and increases the opportunity for probiotic species to influence the host’s microbial balance and gastrointestinal immune system [69,70,71].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [70]
In the citing paper
“It has been noted that adhesion to intestinal surfaces is one of the main selection criteria for probiotic bacteria, as well as a lack of platelet aggregation, as this has been shown to be harmful to the host and potentially leads to endocarditis.”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [70]
Citations
Cites
Functional food science and gastrointestinal physiology and function
Salminen, S., Bouley, C., Boutron, M.-C., Cummings, J. H., Franck, A., Gibson, G. R., Isolauri, E., Moreau, M.-C., Roberfroid, M., & Rowland, I. (1998) · British Journal of Nutrition · doi:10.1079/bjn19980108 · Cited by 1,398
Self-citationVANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,226
Structure, biochemistry and mechanism of action of glycopeptide antibiotics
Reynolds, P. E. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967563 · Cited by 699
Salminen, S. (1993) · Medical Entomology and Zoology · Cited by 659
Self-citationBugg, T. D. H., Wright, G. D., Dutka-Malen, S., Arthur, M., Courvalin, P., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 650
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Arthur, M., Molinas, C., Depardieu, F., & Courvalin, P. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.117-127.1993 · Cited by 603
Marteau, P., Minekus, M., Havenaar, R., & Huis In’t Veld, J. H. J. (1997) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(97)76027-2 · Cited by 488
Johansson, M. L., Molin, G., Jeppsson, B., Nobaek, S., Ahrné, S., & Bengmark, S. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.1.15-20.1993 · Cited by 426
Lactic acid bacteria and human clinical infection
Aguirre, M., & Collins, M. D. (1993) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1993.tb02753.x · Cited by 425
Cited by
Probiotic bacteria: safety, functional and technological properties
Saarela, M., Mogensen, G., Fondén, R., Mättö, J., & Mattila-Sandholm, T. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(00)00375-8 · Cited by 1,202
“Current safety criteria for successful probiotics have been defined in several reviews (Lee and Salminen, 1995; Donohue and Salminen, 1996; Salminen et al., 1996b, 1998b; Adams, 1999).”
BackgroundInfluentialSelf-citationAnal, A. K., & Singh, H. (2007) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2007.01.004 · Cited by 1,006
Probiotics for treating acute infectious diarrhoea
Allen, S. J., Martinez, E. G., Gregorio, G. V., & Dans, L. F. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003048.pub3 · Cited by 628
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., & Johnston, B. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub4 · Cited by 607
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Wells, J. M., & Mercenier, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1840 · Cited by 537
“Some clinical reports have drawn attention to rare and isolated cases of infection with Lactobacillus spp., usually in severely immunocompromized patients 91, 92 .”
Background
Metadata
- Authors
- Salminen, S.
- Affiliations
- University of Turku (FI)
- Corresponding author
- Salminen, S
- ORCID
- Salminen, S
- Venue
- International Journal of Food Microbiology
- Publisher
- Elsevier BV
- Published
- 1998-10-20
- Volume
- 44
- Issue
- 1-2
- Pages
- 93-106
- ISSN
- 0168-1605 (ISSN-L)
- OpenAlex
- W2105634693
- Cited by
- 884
- References
- 83
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 26 · 2023: 27 · 2022: 27 · 2021: 30 · 2020: 32 · 2019: 33 · 2018: 27 · 2017: 24 · 2016: 32 · 2015: 44 · 2014: 59 · 2013: 40 · 2012: 55
- FWCI
- 35.18
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- International Journal of Food Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Agricultural and Biological Sciences › Food Science › Agricultural safety and regulations
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- probiotics, probiotic safety, lactic acid bacteria, GRAS, antibiotic resistance, plasmid-mediated resistance, vancomycin resistance, Enterococcus, Lactobacillus, Lactococcus, Streptococcus, fermented dairy products, adverse effects, risk-benefit assessment
- MeSH terms
- Animals, Clinical Trials as Topic, Drug Resistance, Microbial, Humans, Lactobacillus, Plasmids, Vancomycin, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Demonstration of safety of probiotics—A review. https://app.cochat.ai/papers/10.1016/s0168-1605(98)00128-7
- The paper
- Salminen, S. (1998). Demonstration of safety of probiotics—A review. International Journal of Food Microbiology. https://doi.org/10.1016/s0168-1605(98)00128-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.